INS and obesity disorder: A study involving the genetic ablation of CRP in rats has shown that CRP is not only a biomarker for metabolism and inflammation but also directly affects energy balance, body weight, insulin sensitivity, and glucose homeostasis by regulating central leptin effects and hypothalamic signaling, thereby influencing the development of obesity [61].